Vaccine Development, the China Dilemma, and International Regulatory Challenges

Authors

Peter K. Yu, Texas A&M University School of LawFollow

Document Type

Article

Publication Date

10-2023

Journal Title

New York University Journal of International Law and Politics

ISSN

0028-7873

Abstract

This article examines the role played by China in the development of international regulatory standards at the intersection of intellectual prop- erty, international trade, and public health. It begins by briefly discussing the role China has played in the global health arena during the COVID-19 pandemic. The article then highlights the difficulty in determining how best to engage with the country in the development of new international regula- tory standards. It shows that the preferred method of engagement will likely depend on one’s perspective on China’s potential contributions and hin- drances: a perspective that focuses on global competition—in the economic, trade, and technological arenas—is likely to differ significantly from one emphasizing global health. This article concludes by providing four key takeaways concerning the challenges and complications that China has posed, or will pose, to policymakers in the development of new international regulatory standards.

First Page

739

Last Page

782

Num Pages

44

Volume Number

55

Issue Number

3

Publisher

New York University School of Law

Recommended Citation

Peter K. Yu, Vaccine Development, the China Dilemma, and International Regulatory Challenges, 55 N.Y.U. J. Int'l L. & Pol. 739 (2023).
Available at: https://scholarship.law.tamu.edu/facscholar/1929

File Type

PDF